Alabama Attorney General Steve Marshall has rallied 21 states in filing a brief supporting Louisiana’s lawsuit against a Biden-era FDA rule that expands access to chemical abortion drugs via mail and telehealth, overriding pro-life protections.
The 2023 rule removed longstanding safeguards on mifepristone, allowing out-of-state providers to prescribe the drug despite contrary state laws, undermining the Supreme Court’s Dobbs decision that returned abortion policy to the states.
Marshall declared the rule unlawful, stating it eliminates critical safety measures, violates federal law on mailing abortion drugs, and empowers providers from states like California and New York to impose their policies on pro-life jurisdictions. The brief argues this intrusion erodes state sovereignty and harms unborn life, while straining health systems and Medicaid programs with increased complications from unregulated abortions.
The coalition, led by Nebraska, includes attorneys general from Alabama, Alaska, Arkansas, Georgia, Idaho, Indiana, Iowa, Kansas, Mississippi, Missouri, Montana, North Dakota, Ohio, Oklahoma, South Carolina, South Dakota, Texas, Utah, West Virginia, and Wyoming.
Louisiana seeks an injunction to block the rule in federal court. This challenge highlights the ongoing battle to protect the vulnerable unborn from federal overreach that prioritizes abortion access over safety and moral principles. By enabling mail-order terminations, the rule facilitates the destruction of innocent lives without adequate oversight, conflicting with states’ rights to uphold the sanctity of life from conception.
Discussion about this post